Diabetic hypoglycemia occurs when a person's blood sugar level falls too low. Symptoms can include: shakiness, confusion or ...

If you’re the kind of person who Googles your health symptoms (no judgment!) you may realize that these experiences could ...

We are pleased to complete the last subject visit in our Phase 1 trial of MBX 1416 in healthy adults and extend our sincere appreciation to the participants, investigators and clinical team for their ...

Wearing a CGM has made living with diabetes much more manageable for a few reasons. The sensor alerts me when I have high ...

American Diversified Holdings Corporation (ADHC) Retains Dr. Stephen C. Weber, MD, FACS As Head of Medical Advisory Board ...

In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment ...

In a report released today, Joel Beatty from Robert W. Baird upgraded Amylyx Pharmaceuticals Inc (AMLX – Research Report) to a Buy, with a ...

Baird analyst Joel Beatty upgraded Amylyx (AMLX) to Outperform from Neutral with a price target of $11, up from $3. The firm has become more ...

Zucara Therapeutics Inc., a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with diabetes, announced that ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

Smart ring maker Oura Health Oy is getting a $75 million investment from medical device firm Dexcom Inc., setting the stage for the two companies to share data and cross-sell products.

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...